DuPont Position Statement on Animal Testing

DuPont conducts laboratory animal testing and livestock feeding trials in order to bring beneficial products to consumers, to maintain our commitment to safety, health and the environment, and to comply with regulatory requirements.  Our use of animals, in both product development and chemical safety assessment, consistently reflects our concern for the welfare and ethical treatment of these animals.

DuPont shares society's desire to increase the use of scientifically validated alternative methods that reduce, refine or replace the use of animal models in research.  We are strong proponents of "intelligent" testing strategies, which minimize the use of animal testing by using a tiered approach to data collection.

DuPont supports these commitments through the following actions:

  • We ensure that all studies involving animals comply with all applicable laws, regulations and licensing requirements.
  • Our toxicology laboratories have been fully accredited since 1979 by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. Our livestock research center adheres to animal use  and care guidelines created by the Federation of Animal Science Societies.
  • We conduct research only at laboratories that possess appropriate facilities and trained, competent staff capable of humane animal care techniques.  We require that all studies be scientifically and ethically justified, and that every study be designed to avoid or minimize pain, discomfort and distress.
  • We use structural and social environmental measures wherever practical and appropriate, such as animal enrichment devices, group housing with solid  flooring and opportunities for animals to interact and move around. In addition, for any testing performed by laboratories external to DuPont, we ensure that the laboratories use enrichment measures that meet our internal standards.
  • We maintain, and continue to enhance, capabilities for tiered data development   to complement, reduce or replace animal testing.  This includes capabilities for extensive literature searching, computer modeling, and in vitro assays (typically conducted with cultured cells, cell fractions or bacteria).
  • We work toward the development, validation and adoption of alternatives to animal testing through our participation in industry associations, as well as through work conducted in our own laboratories.
  • We actively participate in industrial consortia to minimize or eliminate duplicative testing.
  • We will not conduct, nor contract for, research on great apes such as chimpanzees, gorillas, bonobos and orangutans.

DuPont is confident that scientific advances in animal research and toxicology will enable us to further significantly reduce our reliance on animal testing, while continuing to ensure product safety for humans and the environment.

For details on non-animal testing alternatives for nanomaterials, please click here.

12/2/12